PuSH - Publication Server of Helmholtz Zentrum München

Merle, D.A.* ; Witternigg, A.* ; Tam-Amersdorfer, C.* ; Hartlmüller, C. ; Spreitzer, E.* ; Schrank, E.* ; Wagner-Lichtenegger, S.* ; Werzer, O.* ; Zangger, K.* ; Kungl, A.J.* ; Madl, T.* ; Meyer, N.H.* ; Falsone, S.F.*

Increased aggregation tendency of alpha-synuclein in a fully disordered protein complex.

J. Mol. Biol. 431, 2581-2598 (2019)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
The recent discovery of biologically active fully disordered, so called random fuzzy protein protein interactions leads to the question of how the high flexibility of these protein complexes correlates to aggregation and pathologic misfolding.We identify the structural mechanism by which a random fuzzy protein complex composed of the intrinsically disordered proteins alpha-Synuclein and SERF1a is able to potentiate cytotoxic aggregation. A structural model derived from an integrated NMR/SAXS analysis of the reconstituted aSyn:SERF1a complex enabled us to observe the partial deprotection of one precise aSyn amyloid nucleation element in the fully unstructured ensemble. This minimal exposure was sufficient to increase the amyloidogenic tendency of SERF1a-bound aSyn.Our findings provide a structural explanation of the previously observed pro-amyloid activity of SERF1a. They further demonstrate that random fuzziness can trigger a structurally organized disease-associated reaction such as amyloid polymerization.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.067
1.243
7
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Fuzzy Complexes ; Intrinsically Disordered Proteins ; Amyloids ; Alpha Synuclein ; Moag-4/serf; Nmr; Promotes; Mechanism; Dynamics; Binding; Order
Language
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0022-2836
e-ISSN 1089-8638
Quellenangaben Volume: 431, Issue: 14, Pages: 2581-2598 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place 24-28 Oval Rd, London Nw1 7dx, England
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503000-001
Scopus ID 85065793752
PubMed ID 31034892
Erfassungsdatum 2019-05-14